Aura Biosciences (AURA) Revenue & Revenue Breakdown
Aura Biosciences Revenue Highlights
00
Aura Biosciences Revenue by Period
Aura Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Aura Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $2.06M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Aura Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
IMTX | Immatics | $54.00M | $30.45M |
ADAG | Adagene | $18.11M | $833.34K |
SEER | Seer | $16.66M | $4.03M |
CRNX | Crinetics Pharmaceuticals | $4.01M | - |
OPT | Opthea | $108.41K | $61.27K |
ANEB | Anebulo Pharmaceuticals | - | - |
CGEM | Cullinan Oncology | - | - |
RZLT | Rezolute | - | - |
ALXO | ALX Oncology | - | - |
CCCC | C4 Therapeutics | - | - |
ANTX | AN2 Therapeutics | - | - |
AURA | Aura Biosciences | - | - |
BCAB | BioAtla | - | $11.00M |
AVTE | Aerovate Therapeutics | - | - |
ACRV | Acrivon Therapeutics | - | - |
ORIC | ORIC Pharmaceuticals | - | - |